Valuation: Cenra Inc.

Market Cap 4.89B 150M 134M 123M 112M 209M 14.22B 213M 1.47B 591M 7.48B 562M 550M 23.6B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.14B 219M 196M 180M 163M 306M 20.79B 311M 2.15B 863M 10.94B 822M 804M 34.49B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.48%
Yield 2024
2.72%
Yield 2025 3.01%
1 day-0.74%
1 week-0.30%
1 month-1.32%
3 months+2.29%
6 months+5.84%
Current year+0.45%
1 week 33.4
Extreme 33.4
33.95
1 month 33.4
Extreme 33.4
34.6
Current year 31.55
Extreme 31.55
37.65
1 year 31.55
Extreme 31.55
37.65
3 years 29
Extreme 29
44.55
5 years 29
Extreme 29
44.55
10 years 29
Extreme 29
44.55
Manager TitleAgeSince
Director of Finance/CFO - 07/03/2014
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 27/05/2016
Chairman - 05/11/2020
Director/Board Member - 17/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-0.30%-1.32% - 150M
+3.19%+11.31%+64.28%+155.66% 1,263B
-0.73%+3.56%+44.65%+83.74% 658B
+1.41%+3.24%+35.25%+106.98% 521B
+0.42%+3.20%+55.81%+69.71% 391B
+2.18%+2.93%+73.90%+45.38% 369B
+1.12%+4.52%+34.76%+57.00% 307B
+6.96%+8.86%+11.95%+35.06% 290B
+1.15%+6.09%+56.15%+78.66% 252B
+3.06%+9.38%+42.48%+112.84% 212B
Average +1.80%+5.28%+41.79%+82.78% 426.21B
Weighted average by Cap. +2.01%+6.60%+50.51%+99.19%

Financials

2024 2025
Net sales 8.92B 273M 245M 225M 204M 381M 25.95B 389M 2.69B 1.08B 13.65B 1.03B 1B 43.05B 8.57B 263M 235M 216M 196M 366M 24.94B 373M 2.58B 1.04B 13.12B 986M 965M 41.37B
Net income 317M 9.73M 8.71M 8.01M 7.26M 13.57M 923M 13.82M 95.55M 38.36M 486M 36.5M 35.72M 1.53B 300M 9.2M 8.24M 7.58M 6.86M 12.83M 873M 13.07M 90.34M 36.27M 459M 34.51M 33.78M 1.45B
Net Debt 2.46B 75.3M 67.44M 62.04M 56.21M 105M 7.15B 107M 740M 297M 3.76B 283M 277M 11.86B 2.26B 69.16M 61.94M 56.97M 51.62M 96.49M 6.57B 98.3M 679M 273M 3.45B 260M 254M 10.89B
Projected Income Statement - Annual - Cenra Inc.
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
Date Price Change Volume
30/10/26 NT$33.55 -0.74% 153,239
29/10/26 NT$33.80 -.--% 73,535
28/10/26 NT$33.80 +0.30% 76,329
  1. Stock Market
  2. Stocks
  3. 3716 Stock